The automated measurement of temporoparietal brain region volumes is a highly accurate predictor of memory loss in healthy elderly persons, indicating that these underlying characteristics could help clinicians identify likely cases of pre-clinical Alzheimers and enable them eventually to prevent the diseases progression, according to an article published in the June issue of Radiology.

The European Commission has approved apixaban (Eliquis) in the 27 countries of the European Union (EU) for the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. This decision marks the first approval for apixaban, a new oral direct Factor Xa inhibitor being developed by the alliance of Bristol-Myers Squibb and Pfizer.

Has your organization implemented an innovative imaging connectivity project in the last 24 months? Can you provide data demonstrating its impact on staffing, patient wait times, report turn-around time, reduced errors or other quality metrics? Has your hospital, health system, imaging center or physician practice seamlessly integrated imaging and IT systems to provide physicians with immediate, anywhere access to patient data? Do you have the ROI and soft ROIplus high patient and staff satisfaction numbersto prove it?

The American Cancer Society released a report on May 19 showing mixed results for cancer prevention in the U.S., with obesity trends beginning to level off just as states dramatically cut funding for tobacco control and long-term declines in smoking appear to have reached their limits.

The Atomic Energy of Canada Limited has reported that its Chalk River Laboratories will undergo a 33-day planned outage, which began on May 15 as part of its ongoing operations of the National Research Universal nuclear reactor.

The Agency for Healthcare Research and Quality desperately needs to restructure the U.S. Preventive Services Task Force (USPSTF), which more than a dozen organizations claim suffers from a lack of transparency and nonrepresentation of key medical specialties.

Combined screening with a CA-125 blood test and transvaginal ultrasound for early detection of ovarian cancer did not reduce the risk of dying from the disease and resulted in a large number of false positives and related biopsies and follow-up procedures, according to a study to be presented during the annual meeting of the American Society of Clinical Oncology June 3-7 in Chicago.

Orthopedic Associates has installed Swissray International ddR Formula DR technology.